Evaluation the Injectability of Injectable Microparticle Delivery Systems on the Basis of Injection Force and Discharged Rate.
暂无分享,去创建一个
Fuzheng Ren | Jia Zeng | Linglin Feng | Yu Liu | Fang Li | Xingchen Cao | Yan Liu | Man Xue | Chuncao Zhao | Zhihan Zhu | Feng Pan | Yilin Guo | Yanhong Zhao | Ziyi Yang
[1] Liandong Hu,et al. Applications and prospects of intra-articular drug delivery system in arthritis therapeutics. , 2022, Journal of controlled release : official journal of the Controlled Release Society.
[2] Su-Tae Kang,et al. Prediction of the Rheological Properties of Fresh Cementitious Suspensions Considering Microstructural Parameters , 2022, Materials.
[3] Y. Zhang,et al. Injectable immunomodulation-based porous chitosan microspheres/HPCH hydrogel composites as a controlled drug delivery system for osteochondral regeneration. , 2022, Biomaterials.
[4] M. Prausnitz,et al. Clinical translation of long-acting drug delivery formulations , 2022, Nature Reviews Materials.
[5] Hongzhong Chen,et al. Polymeric microneedle‐mediated sustained release systems: Design strategies and promising applications for drug delivery , 2021, Asian journal of pharmaceutical sciences.
[6] D. Kozak,et al. Impact of Particle Flocculation on the Dissolution and Bioavailability of Injectable Suspensions. , 2021, International journal of pharmaceutics.
[7] Robert Langer,et al. Modeling, design, and machine learning-based framework for optimal injectability of microparticle-based drug formulations , 2020, Science Advances.
[8] T. Niwa,et al. [Research on Gliding and Discharge Performance of Suspended Injection from Syringe -Effect of Diameter Ratio of Suspending Particle against Needle Hole on Needle Passageability]. , 2020, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[9] Aniruddha Bose,et al. Filling the Gap: A Correlation between Objective and Subjective Measures of Injectability , 2020, Advanced healthcare materials.
[10] Hetal Khatri,et al. Injectability as a function of viscosity and dosing materials for subcutaneous administration , 2019, International journal of pharmaceutics.
[11] C. Regillo,et al. Comparing 33-Gauge versus 30-Gauge Needles for Intravitreal Injections. , 2018, Ophthalmology. Retina.
[12] Kazu Takeda,et al. Optimal range of injection rates for a lymphatic drug delivery system , 2018, Journal of biophotonics.
[13] K. Shakesheff,et al. Improved delivery of PLGA microparticles and microparticle‐cell scaffolds in clinical needle gauges using modified viscosity formulations , 2018, International journal of pharmaceutics.
[14] A. Vo,et al. The Biomechanics and Optimization of the Needle-Syringe System for Injecting Triamcinolone Acetonide into Keloids , 2016, Journal of medical engineering.
[15] Ahmed Besheer,et al. Calculation of injection forces for highly concentrated protein solutions. , 2015, International journal of pharmaceutics.
[16] C. Park,et al. Needle-free transdermal delivery using PLGA nanoparticles: effect of particle size, injection pressure and syringe orifice diameter. , 2014, Colloids and surfaces. B, Biointerfaces.
[17] A. Şişman,et al. The effects of different syringe volume, needle size and sample volume on blood gas analysis in syringes washed with heparin , 2012, Biochemia medica.
[18] P. Minghetti,et al. Injectability Evaluation: An Open Issue , 2011, AAPS PharmSciTech.
[19] F. Agnely,et al. Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[20] Lieven Baert,et al. Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] M. Kurisawa,et al. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[22] R. Bodmeier,et al. Injectability of biodegradable in situ forming microparticle systems (ISM). , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] Z. Lian,et al. A biomechanical model for real-time simulation of PMMA injection with haptics , 2008, Comput. Biol. Medicine.
[24] F. Debruyne,et al. Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer. , 2006, Future oncology.
[25] M J Hawkins,et al. Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[26] Mayur M. Patel,et al. Long-Acting Injectables: Current Perspectives and Future Promise. , 2019, Critical reviews in therapeutic drug carrier systems.
[27] E. Stefánsson,et al. Microspheres and Nanotechnology for Drug Delivery. , 2016, Developments in ophthalmology.
[28] J. Gerancher,et al. DepoDur® (extended-release epidural morphine): a review of an old drug in a new vehicle , 2007 .